// startup autopsy
Viome
Microbiome testing and personalized nutrition startup backed by Bill Gates that raised $87M and hit conversion walls.
timingMass Layoff Spiral
Cascading layoffs that accelerated the decline · Fatal mistake: Model Failure
| Founded | 2016 |
|---|---|
| Closed | 2024 |
| Country | USA |
| Sector | Healthtech |
// the model, blind
Evaluating only Viome’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Market timing.
Key Events Timeline
FOUNDING
Viome founded to provide consumer microbiome testing and personalized dietary recommendations based on gut bacteria analysis.
FUNDING
Viome raises $87 million in funding from Bill Gates, SoftBank, and other prominent investors backing the microbiome testing market opportunity.
PRODUCT LAUNCH
Viome expands supplement subscription offerings as a recurring revenue stream following initial microbiome test sales priced at $100-200.
DOWN ROUND
Viome faces chronic conversion and retention challenges as supplement subscription churn rates soar and one-time test purchases fail to generate sustained revenue.
REGULATORY ACTION
Scientific validation for microbiome-based dietary recommendations remains contested by the medical community, undermining Viome's core value proposition.
LAYOFF
Viome cuts 25% of its workforce as the company struggles to achieve profitability and sustainability amid declining customer retention.
SHUTDOWN
Viome ceases all operations and significantly scales back business following inability to establish sustainable consumer microbiome testing model.